BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15871083)

  • 21. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients.
    Hayashi K; Ina H; Tezuka M; Okada Y; Irie T
    Cardiovasc Intervent Radiol; 2007; 30(6):1144-55. PubMed ID: 17909884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation.
    Yu CY; Ou HY; Weng CC; Huang TL; Chen TY; Leung-Chit L; Hsu HW; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1045-8. PubMed ID: 27320552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma.
    Heinzow HS; Meister T; Nass D; Köhler M; Spieker T; Wolters H; Domschke W; Domagk D
    Scand J Gastroenterol; 2011 Feb; 46(2):201-10. PubMed ID: 20969491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation.
    Ko HK; Ko GY; Yoon HK; Sung KB
    Korean J Radiol; 2007; 8(4):320-7. PubMed ID: 17673843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
    Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial blood supply to the posterior aspect of segment IV of the liver from the caudate branch: demonstration at CT after iodized oil injection.
    Miyayama S; Matsui O; Taki K; Minami T; Ryu Y; Ito C; Nakamura K; Inoue D; Takamatsu S
    Radiology; 2005 Dec; 237(3):1110-4. PubMed ID: 16251397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?
    Kim JM; Kwon CH; Joh JW; Kim SJ; Shin M; Kim EY; Moon JI; Jung GO; Choi GS; Lee SK
    Transplant Proc; 2010 Apr; 42(3):821-4. PubMed ID: 20430181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
    Terzi E; Ray Kim W; Sanchez W; Charlton MR; Schmeltzer P; Gores GJ; Andrews JC; Smyrk TC; Heimbach JK
    Liver Transpl; 2015 Feb; 21(2):248-57. PubMed ID: 25371111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Three (3) cases of advanced hepatocellular carcinoma (HCC) treated successfully by transcatheter arterial chemoembolization (TACE) using lipiodol and a fine- powder formulated cisplatin (DH)].
    Kasai K; Kuroda H; Ushio A; Miyamoto Y; Sawara K; Miyasaka A; Takikawa Y; Suzuki K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):479-83. PubMed ID: 19295276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
    Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
    Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).
    Zangos S; Eichler K; Balzer JO; Straub R; Hammerstingl R; Herzog C; Lehnert T; Heller M; Thalhammer A; Mack MG; Vogl TJ
    Eur Radiol; 2007 Feb; 17(2):553-63. PubMed ID: 16896704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoembolization in patients at high risk: results and complications.
    Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
    J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.